Back to Search
MICHAEL KLEVEN, DO
DO
Family Medicine Physician
NPI: 1447323423IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
3680(AZ)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE
Class of 2000
Research & Publications (16)
Differences among conventional, atypical and novel putative D(2)/5-HT(1A) antipsychotics on catalepsy-associated behaviour in cynomolgus monkeys.
PMID 19464324·Behav Brain Res·2009
4-observational
Effects of norketamine enantiomers in rodent models of persistent pain.
PMID 18586315·Pharmacol Biochem Behav·2008
7-preclinical
Induction by antipsychotics of "win-shift" in the drug discrimination paradigm.
PMID 17431135·J Pharmacol Exp Ther·2007
7-preclinical
F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. II. Activity in models of positive symptoms of schizophrenia.
PMID 17375086·Br J Pharmacol·2007
7-preclinical
F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. III. Activity in models of cognition and negative symptoms.
PMID 17375085·Br J Pharmacol·2007
7-preclinical
Pharmacological profiles in rats of novel antipsychotics with combined dopamine D2/serotonin 5-HT1A activity: comparison with typical and atypical conventional antipsychotics.
PMID 17351418·Behav Pharmacol·2007
4-observational
Actions of novel antipsychotic agents on apomorphine-induced PPI disruption: influence of combined serotonin 5-HT1A receptor activation and dopamine D2 receptor blockade.
PMID 16421514·Neuropsychopharmacology·2006
7-preclinical
Antipsychotic-like vs cataleptogenic actions in mice of novel antipsychotics having D2 antagonist and 5-HT1A agonist properties.
PMID 16237379·Neuropsychopharmacology·2006
7-preclinical
Effects of novel antipsychotics with mixed D(2) antagonist/5-HT(1A) agonist properties on PCP-induced social interaction deficits in the rat.
PMID 16009387·Neuropharmacology·2005
7-preclinical
Novel antipsychotic agents with 5-HT(1A) agonist properties: role of 5-HT(1A) receptor activation in attenuation of catalepsy induction in rats.
PMID 15996562·Neuropharmacology·2005
4-observational
Anticataleptic properties of alpha2 adrenergic antagonists in the crossed leg position and bar tests: differential mediation by 5-HT1A receptor activation.
PMID 15448976·Psychopharmacology (Berl)·2005
7-preclinical
Ability of dopamine antagonists to inhibit the locomotor effects of cocaine in sensitized and non-sensitized C57BL/6 mice depends on the challenge dose.
PMID 14668976·Psychopharmacology (Berl)·2004
4-observational
Depletion of 5-HT disrupts prepulse inhibition in rats: dependence on the magnitude of depletion, and reversal by a 5-HT precursor.
PMID 11850148·Neuropsychopharmacology·2002
7-preclinical
Repeated treatment with 8-OH-DPAT induces tolerance to its ability to produce the 5-HT1A behavioural syndrome, but not to its ability to attenuate haloperidol-induced catalepsy.
PMID 11103884·Behav Pharmacol·2000
4-observational
Effects of WAY 100635 on antipsychotic-induced catalepsy in 5-HT depleted animals: a role for tonic activation of 5-HT(1A) receptors.
PMID 10794820·Eur J Pharmacol·2000
7-preclinical
The effects of antipsychotics with 5-HT(2C) receptor affinity in behavioral assays selective for 5-HT(2C) receptor antagonist properties of compounds.
PMID 10657547·Eur J Pharmacol·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 17218 N 72ND DR STE 100
GLENDALE, AZ 85308 - Phone
- (623) 334-8671
Quick Facts
- NPI
- 1447323423
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 26
- Publications
- 16
Are you this provider?
Claim Your Profile